Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Regulation

FDA

FDA Installs Tracy Beth Hoeg as Acting CDER Director as Pazdur Files Retirement

The acting appointment underscores internal rifts over rapid‑review plans that have unsettled stakeholders.

FDA Names Richard Pazdur to Lead Drug Review Center

FDA to Remove Most Boxed Warnings From Menopause Hormone Therapies

FDA Class II Recall Targets 580,000 Prazosin Bottles for Nitrosamine Overages

FDA Posts More Than 100 Warning Letters in Drug Ad Crackdown, Targeting Hims, Lilly and Novo

Sarepta Temporarily Halts Elevidys Shipments Under FDA Request

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research